The diagnosis of Waldenström's macroglobulinemia (WM), an IgM-associated lymphoplasmacytic lymphoma, can be challenging due to the different forms of disease …
S Zanwar, JP Abeykoon - Therapeutic Advances in …, 2022 - journals.sagepub.com
Waldenström macroglobulinemia (WM) is an indolent lymphoplasmacytic lymphoma. Recent strides made in the genomic profiling of patients with WM have led to the identification of …
S Oubari, E Naser, M Papathanasiou… - European Journal of …, 2021 - Wiley Online Library
Objective To study the impact of time to diagnosis on cardiac Mayo stages, treatment outcome, and overall survival. Methods We retrospectively analyzed 77 consecutive patients …
S Zanwar, JP Abeykoon, SM Ansell… - British journal of …, 2021 - Wiley Online Library
Patients with asymptomatic/smouldering Waldenström macroglobulinaemia (SWM) have a variable risk of progression to active WM. Our study evaluated 143 patients with SWM …
M Bibas, S Sarosiek, JJ Castillo - Mediterranean Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Waldenström macroglobulinemia (WM) is an infrequent variant of lymphoma, classified as a B-cell malignancy identified by the presence of IgM paraprotein, infiltration of clonal, small …
JN Gustine, RE Szalat, A Staron, T Joshi… - …, 2022 - pmc.ncbi.nlm.nih.gov
Light chain (AL) amyloidosis is an uncommon clinical manifestation of Waldenström macroglobulinemia (WM), an IgM-secreting lymphoplasmacytic lymphoma characterized by …
S Zanwar, P Kapoor - Journal of the National Comprehensive Cancer …, 2024 - jnccn.org
Waldenström macroglobulinemia (WM) is a B-cell lymphoma characterized by the presence of bone marrow lymphoplasmacytic infiltration and circulating monoclonal immunoglobulin …
G Merlini, S Sarosiek, G Benevolo, X Cao… - Seminars in …, 2023 - Elsevier
Abstract Consensus Panel 6 (CP6) of the 11th International Workshop on Waldenström's Macroglobulinemia (IWWM-11) was tasked with reviewing the state of the art for diagnosis …